National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The registry aims to document epidemiologic data, treatment and long-term outcome as well as quality of life of patients with APL. Additionally, a biobanking project for further translational studies is integrated. Prospective population-based non-interventional and non-randomized multicenter registry.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• newly-diagnosed APL (either de novo or therapy-related), within 12 months of diagnosis

• or relapsed APL, within 12 months of diagnosis of relapse

‣ confirmed by the presence of the translocation t(15; 17)

⁃ and / or confirmed by the detection of the fusion transcript of PML/RARa

Locations
Other Locations
Germany
Prof. Dr. U. Platzbecker
RECRUITING
Dresden
Contact Information
Primary
Uwe Platzbecker, Prof. Dr.
Uwe.Platzbecker@medizin.uni-leipzig.de
+49 351 458 3192
Backup
Michaela Weier
michaela.weier@ukdd.de
+49 351 458 3192
Time Frame
Start Date: 2014-07
Estimated Completion Date: 2024-12
Participants
Target number of participants: 500
Treatments
observational
Sponsors
Leads: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

This content was sourced from clinicaltrials.gov